R&D Solutions

Frequently Asked Questions

Research and development (R&D) teams can handle a variety of sensitive information types, including intellectual property (IP) like formulas, data, prototypes, and software code; proprietary information such as trade secrets and financial results; confidential customer data; and confidential employee information. Some R&D teams may also handle personal information such as medical and health records, biometric data, and personally identifiable information (PII).

Research and development (R&D) teams face the risk of unauthorized access to sensitive information whenever they send, receive, or collaborate on sensitive content. Unauthorized access can lead to data breaches and data privacy violations which in turn can lead to intellectual property theft by criminal syndicates or industry competitors. Compliance violations for regulations such as HIPAA, Sarbanes-Oxley, and GDPR are also a risk factor. To mitigate these and other risks to intellectual property, R&D teams should ensure that all data is protected by strong authentication and access control measures, as well as encrypted in transit and at rest so only authorized employees and trusted partners have access.

Research and development (R&D) teams can protect intellectual property in many different ways. They can, for example, utilize secure cloud technologies to store and share data, encrypt sensitive information, regularly update and patch systems and applications, implement multi-factor authentication for developers, and more. Additionally, R&D teams can deploy secure coding practices, secure their physical environment, use secure tools and frameworks, and limit privileged access to key personnel. Finally, ongoing security testing and monitoring helps ensure that all data is safe and secure. These and other practices will help protect R&D teams and the intellectual property they process and share.

Yes, research and development (R&D) teams do have to demonstrate compliance with GxP. This may include demonstrating compliance with Good Clinical Practice (GCP) as well as other relevant guidance, such as Good Manufacturing Practice (GMP) and Good Laboratory Practice (GLP). R&D teams must ultimately ensure that their products meet all specified regulatory requirements and that their development processes are well-documented and monitored. In addition, R&D teams need to demonstrate that the appropriate personnel are trained and qualified for the tasks assigned to them and that the data generated is accurate and complete.

Research and development (R&D) departments in many industries have certain compliance regulations with which they must comply. Regulatory compliance, regardless of industry, government, or region, typically includes ensuring any new technologies they develop, create, or modify adhere to specific, rigorous safety standards. They must also ensure that data gathered, produced, or stored meets cybersecurity and/or data privacy requirements. Proper documentation must be maintained to demonstrate compliance with these and other regulations. Additionally, R&D departments should have processes in place to routinely assess compliance with all applicable regulations.